Quick Answer
LakeShore Biopharma Co., Ltd. reported Net Income of -$99.98 million for fiscal year 2025.
LakeShore Biopharma Co., Ltd. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$99.98M | +76.9% |
| 2024 | -$433.46M | -198.0% |
| 2023 | -$145.48M | -37.2% |
| 2022 | -$106.00M | +44.7% |
| 2021 | -$191.83M | — |
- LakeShore Biopharma Co., Ltd. showed an increase of +76.9% in Net Income compared to the prior fiscal year.
- Over the 2021–2025 period, LakeShore Biopharma Co., Ltd.’s net income has grown by 47.9% (from -$191.83 million to -$99.98 million).
- The most recent figure is from LakeShore Biopharma Co., Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on July 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: